50 subscribers
Offline dengan aplikasi Player FM !
New trick for old drug; Vascepa cost effective for CV reduction
Manage episode 247601805 series 2355282
Icosapent ethyl cost effective in REDUCE-IT analysis Treatment with the fish-derived drug Vascepa for CV event reduction is more effective and less costly than placebo.
* * *
Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019
* * *
DAPA-HF: Dapagliflozin benefits regardless of age, HF severity The SGLT2 inhibitor had similar efficacy in the elderly and across the spectrum of baseline symptom status.
Colchicine cut post-MI CVD events Colchicine fulfilled the promise first seem in CANTOS that anti-inflammatory treatment can reduce cardiovascular disease events.
Cardiac arrests peak with pollution in Japan The incidence of out-of-hospital cardiac arrests in Japan increased on days when counts of particulate matter spiked from the day before.
* * *
For more MDedge Podcasts, go to mdedge.com/podcasts
Email the show: podcasts@mdedge.com
Interact with us on Twitter: @MDedgeTweets
87 episode
Manage episode 247601805 series 2355282
Icosapent ethyl cost effective in REDUCE-IT analysis Treatment with the fish-derived drug Vascepa for CV event reduction is more effective and less costly than placebo.
* * *
Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019
* * *
DAPA-HF: Dapagliflozin benefits regardless of age, HF severity The SGLT2 inhibitor had similar efficacy in the elderly and across the spectrum of baseline symptom status.
Colchicine cut post-MI CVD events Colchicine fulfilled the promise first seem in CANTOS that anti-inflammatory treatment can reduce cardiovascular disease events.
Cardiac arrests peak with pollution in Japan The incidence of out-of-hospital cardiac arrests in Japan increased on days when counts of particulate matter spiked from the day before.
* * *
For more MDedge Podcasts, go to mdedge.com/podcasts
Email the show: podcasts@mdedge.com
Interact with us on Twitter: @MDedgeTweets
87 episode
Semua episode
×
1 Top stories from the American Heart Association scientific sessions 7:42

1 Vascepa gains event-reduction nod; diabetes ups ischemic risks 8:16

1 Post-STEMI events less likely in women; bariatric surgery may lower stroke risk 7:27

1 New trick for old drug; Vascepa cost effective for CV reduction 7:12


1 ISCHEMIA trial, DAPA-HF, and valsartan recall: AHA Special 32:06

1 Long-awaited ISCHEMIA results to change practice, DAPA-HF elevates dapagliflozin for HFrEF 8:42

1 Pot heightens stroke, arrhythmia risks; keeping low LDL and BP slashes lifetime heart risk 8:02

1 How risk factors in childhood translate to CV outcomes in adulthood 8:33

1 Driving while defibrillating; hypertension holds greater risk in black patients 7:51

1 AFib hits Native Americans hard; TAVR shown durable, safe after 5 years 7:38

1 Practice changing prevention data from ESC 2019 Part II 42:06

1 Statins tied to skin, soft tissue infections; new Card Talk episode 41:38

1 Troponin protocol rapidly rules out MI; hidden risk of moderate aortic stenosis 8:51

1 Sun sets on longer DAPT after PCI; inactivity boosts post-MI risk 8:52
Selamat datang di Player FM!
Player FM memindai web untuk mencari podcast berkualitas tinggi untuk Anda nikmati saat ini. Ini adalah aplikasi podcast terbaik dan bekerja untuk Android, iPhone, dan web. Daftar untuk menyinkronkan langganan di seluruh perangkat.